The SPI loses ground on the fourth day of the week.
The SPI was trending 0.78 percent weaker at 17,991.93 points in SIX trading at 3:39 p.m. On the stock exchange, the values contained in the SPI are 2.294 trillion. worth euros. The SPI entered Thursday trading 0.826 percent lower at 17,984.11 points, after 18,133.98 points the previous day.
The daily low of the SPI was 17,941.32 points, while the daily high was 18,058.21 points.
This is how the SPI has developed since the beginning of the year
On a weekly basis, the SPI has recorded gains of 2.75 percent so far. Just a month ago, on March 2nd, 2026, the SPI recorded a value of 19,027.83 points. Three months ago the SIX was closed due to a public holiday. The SPI was quoted at 18,219.49 points on the previous trading day, December 30, 2025. A year ago, on April 2, 2025, the SPI was at 16,790.28 points.
Since the beginning of 2026, the index has already fallen by 1.37 percent. The SPI is currently at an annual high of 19,309.93 points. However, the low for the year was registered at 16,847.58 points.
These are the winners and losers in the SPI
The top stocks in the SPI are currently ASMALLWORLD (+ 9.82 percent to 0.62 CHF), Addex Therapeutics (+ 5.00 percent to 0.04 CHF), BioVersys (+ 4.21 percent to 29.70 CHF), Molecular Partners (+ 4.10 percent to 3.18 CHF) and Feintool International (+ 3.93 percent to 9.00 CHF). The weakest SPI shares, on the other hand, are Montana Aerospace (-10.28 percent to 24.45 CHF), MindMaze Therapeutics (-9.14 percent to 0.32 CHF), ams-OSRAM (-6.98 percent to 8.13 CHF), Cicor Technologies (-6.48 percent to 115.50 CHF) and SoftwareONE (-5.52 percent to 6.17 CHF).
SPI shares: trading volume and market capitalization at a glance
UBS shares currently have the largest trading volume in the SPI. 1,488,538 shares were last traded via SIX. Roche shares currently have the largest market capitalization in the SPI at EUR 282.595 billion.
SPI stock fundamentals
Among SPI stocks this year, Evolva shares have the lowest price-to-earnings ratio (P/E) at 0.36, according to FactSet estimates. At 79.95 percent, Kudelski shares’ 2026 dividend yield is expected to be the strongest among the stocks in the index, according to FactSet estimates.
Editorial team finanzen.net
Selected leveraged products on Addex Therapeutics
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Addex Therapeutics
The leverage must be between 2 and 20
Advertising
